ImmunoGen, Inc.: layoffs
Every layoff notice and restructuring filing on file, newest first, since .
People, last 12 months
0
0 notices and filings
People, all years on file
305
5 notices and filings
Largest year
2019
220 people
Latest
277 employees today
People laid off by year and month
Newest year first. Counted once per month: when an SEC filing and WARN notices fall in the same month, the larger figure is used.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019 | · | · | · | · | · | 220 | · | · | · | · | · | · | 220 |
| 2018 | · | 20 | · | · | · | · | · | · | · | · | · | · | 20 |
| 2016 | · | · | · | · | · | · | · | · | 65 | · | · | · | 65 |
All layoffs
Newest first. A WARN notice is one site in one state; an SEC filing is a company-wide plan, with the number it states.
| Announced | People | Kind | Where | Source |
|---|---|---|---|---|
| Not stated | Restructuring planSEC 8-K | Company-wide plan | Filing | |
| 220 people | Restructuring planSEC 8-K | “(also referred to as “we,” “our”, “us”, or “ImmunoGen”) approved a plan to restructure our business to focus our resources on continued development of mirvetuximab soravtansine and…” | Filing | |
| 20 people | Restructuring planSEC 8-K | “Implementation of the new operating model will result in a net reduction of our workforce by approximately 20 positions by the end of 2018.” | Filing | |
| Not stated | Restructuring planSEC 8-K | Company-wide plan | Filing | |
| 65 people (17% of workforce) | Restructuring planSEC 8-K | “(also referred to as “we,” “our” or “ImmunoGen”) approved a plan to reengineer our business, resulting in a reduction of our workforce by approximately 17%, or 65 positions, which …” | Filing |
Source: State WARN notices (Texas, California, Iowa) and SEC 8-K item 2.05 filings · as of Jun 26, 2019. Notices are linked to ImmunoGen, Inc. by its exact name or by SEC CIK; a notice filed under a differently named subsidiary may be missing